Commentary: Mechanisms of mitral valve development and disease

Category	Detail
Condition	Mitral Valve Disease
Key Mechanisms	Embryologic mechanisms, endothelial injury, inflammatory pathways, genetic predisposition.
Target Population	Patients with rheumatic mitral stenosis, congenital mitral stenosis, myxomatous mitral valve prolapse, and genetic syndromes.
Care Setting	Clinical assessment of mitral valve abnormalities in congenital and syndromic contexts.

Three major mitral phenotypes: rheumatic mitral stenosis, congenital mitral stenosis, myxomatous mitral valve prolapse.
Role of Sonic Hedgehog signalling in atrioventricular canal formation and associated cardiac defects.
Mitral valve abnormalities recognized in genetic syndromes such as Down syndrome and RASopathies.
Mitral leaflet elongation in hypertrophic cardiomyopathy as a primary phenotypic expression.
Collagenopathies highlight heterogeneous developmental pathways leading to mitral pathology.

Patients with mitral valve disease associated with genetic syndromes.

Management strategies should consider the underlying genetic and developmental context.

Integrate developmental biology insights into clinical assessments of mitral valve disease.
Utilize echocardiography to evaluate mitral valve abnormalities in syndromic patients.
Collaborate with genetic specialists for comprehensive management of patients with mitral valve disease.